3NC
ENDP

300 North Capital’s Endo International plc ENDP Stock Holding History

300 North Capital’s Portfolio ENDP Stock Details ENDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-28,620
Closed -$2.57M – 96
2015
Q1 		$2.57M Buy
+28,620
New +$2.39M 0.56% 73

Other funds holding ENDP

JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

300 North Capital's ENDP Position: Q2 2015 in Review

300 North Capital sold out of Endo International plc (ENDP) in Q2 2015, closing a stake of 28,620 shares — an estimated $2.57M sold.

300 North Capital first reported a position in ENDP in Q1 2015 and held it in 1 quarter. The position peaked at $2.57M in Q1 2015. 381 funds tracked by Wall St. Rank hold ENDP as of Q2 2015.

  • 300 North Capital reported no remaining Endo International plc position as of Q2 2015 after selling out during the quarter.
  • 300 North Capital sold 28,620 Endo International plc shares in Q2 2015, an estimated $2.57M.
  • 300 North Capital first reported a position in Endo International plc in Q1 2015 and held it in 1 quarter.
  • 300 North Capital's Endo International plc position peaked at $2.57M in Q1 2015.
  • 381 funds tracked by Wall St. Rank held Endo International plc as of Q2 2015.

Based on 300 North Capital's 13F filing for Q2 2015, filed 30 Jul 2015.